Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR137 host gene (MIR137HG) is a large, non-protein-coding RNA gene located on chromosome 1, serving as the host gene for the microRNA miR-137[3]. MIR137HG itself does not code for a protein but is important as the primary transcript from which miR-137 is processed. Expression and regulation of MIR137HG directly affect the levels of mature miR-137, which plays critical roles in neuronal differentiation, brain development, synaptic function, and acts as a tumor suppressor in various cancers[1][3][4]. Dysregulation or epigenetic silencing (e.g., via CpG methylation) of MIR137HG can lead to reduced levels of miR-137 and is implicated in neuropsychiatric disorders such as schizophrenia and several types of cancer[3][4]. MIR137HG is not considered a direct therapeutic target itself (such as a receptor or enzyme), but its product, miR-137, is being explored for its role in disease pathways and as a biomarker or therapeutic target in neuropsychiatric and oncological conditions[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR137 host gene (non-protein coding) (MIR137HG).